Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6 USD | +2.92% |
|
+12.15% | +64.84% |
06-22 | MannKind Corporation Announces Positive 17-Week Results from the INHALE-3 Study | CI |
05-29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.84% | 1.63B | |
+20.17% | 126B | |
+24.67% | 118B | |
+23.55% | 27.87B | |
-17.74% | 20.95B | |
-16.15% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- Transcript : MannKind Corp. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-10-2013 08